Chemistry: analytical and immunological testing – Biological cellular material tested
Reexamination Certificate
2006-12-26
2006-12-26
Wallenhorst, Maureen M. (Department: 1743)
Chemistry: analytical and immunological testing
Biological cellular material tested
C436S164000, C436S166000, C435S006120
Reexamination Certificate
active
07153691
ABSTRACT:
The present invention is a method of identifying and assessing DNA euchromatin in biological cells. The amount and/or distribution of DNA euchromatin generally relates to RNA/protein synthesis, which may change in certain conditions, such as disease, and/or cellular response to environmental and/or chemical agents. The present invention detects the potential presence of disease by assessing DNA euchromatin in ostensibly normal cells and similarly provides means to monitor and assess treatment response. The present invention may also be used to assess how application (or removal) of influences, such as environment, radiation, chemical agents, medications, herbs, vitamins, etc., interact to effect cells, establishing uses in monitoring wellness and pharmacological screening. Additional uses include assessing age related disorders, allergies, infections, Alzheimer's disease, ‘Time of Death’, chronic fatigue syndrome, etc. The method may be advantageously applied to biological cells including micro-organisms, plants, animals, or cultured cells, alone or in conjunction with other markers.
REFERENCES:
patent: 3957583 (1976-05-01), Gibson
patent: 5016283 (1991-05-01), Bacus
patent: 5168066 (1992-12-01), Zahniser
patent: 5206244 (1993-04-01), Zahler
patent: 5485527 (1996-01-01), Bacus
patent: 5556750 (1996-09-01), Modrich
patent: 5633945 (1997-05-01), Kamentsky
patent: 5643556 (1997-07-01), Gilchrest
patent: 5670621 (1997-09-01), Donahue
patent: 5773219 (1998-06-01), Sanford-Mifflin
patent: 5784162 (1998-07-01), Cabib et al.
patent: 5849595 (1998-12-01), Alfano
patent: 5862304 (1999-01-01), Ravdin
patent: 5871917 (1999-02-01), Duffy
patent: 5889881 (1999-03-01), MacAulay
patent: 5919621 (1999-07-01), Brown
patent: 5936064 (1999-08-01), Baxter
patent: 5942410 (1999-08-01), Lam
patent: 5989811 (1999-11-01), Veltri et al.
patent: 5989816 (1999-11-01), Van Houten
patent: 6026174 (2000-02-01), Palcic
patent: 6035258 (2000-03-01), Freed
patent: 6215892 (2001-04-01), Douglass
patent: 6271035 (2001-08-01), Deka
patent: 6287521 (2001-09-01), Quay
patent: 6316189 (2001-11-01), Haddad
patent: 6348325 (2002-02-01), Zahniser
patent: 6388809 (2002-05-01), MacAulay
patent: 6391026 (2002-05-01), Hung
patent: 6451555 (2002-09-01), Duffy
patent: 6454705 (2002-09-01), Cosentino
patent: 6455593 (2002-09-01), Grimley
patent: 2004/0042646 (2004-03-01), MacAulay et al.
patent: 97/43732 (1997-11-01), None
patent: WO 00/45166 (2000-08-01), None
Soames, Feulgen Hydrolysis Profiles and Acid-labile DNA in Oral Squamous Cell Carcinoma, Oral Oncol., Eur. J. Cancer vol. 318, No. 4, pp. 222-226 (1995).
Sincock, A Semi-Automated Procedure for Aiding the Diagnosis of Cervical Neoplasms Based on the Measurement of Acid-Labile DNA in Exfoliated Cells, Eur. J. Cancer: 31. 733-36 (1983).
Sincock., Quantitative Assessment of Cervical Neoplasms by Hydrolyzed DNA Assay, The Lancet, Oct. 42, 1987.
Sincock, Semiautomated Measurement of Rapidly Hydrolyzed DNA in the Diagnosis of Mammary Carcinoma, Cancer 57:1-5, Jan. 1, 1986.
Sincock, Semi-Automated Diagnosis of Cervical Intra-Epithelial Neoplasia Grade 2 by the Measurement of Acid Labile DNA in Cytologically Normal Nuclei, Cancer 58:83-86, Jul. 1, 1986.
Petrakis, Physiologic, biochemical, and cytologic aspects of nipple aspirate fluid, Breast Cancer Research & Treatment 8:7-19 (1986).
Partington, Quantitative Determination of Acid-Labile DNA in Cervical Intraepithelial Neoplasia, Cancer 67:3104-09 (Jan. 15, 1991).
Ogden, The Effect of Distant Malignancy Upon Quantitative Cytologic Assessment of Normal Oral Mucosa, Cancer 65:477-80 (Feb. 1, 1990).
Millett, Feulgen-hydrolysis profiles in cells exfoliated from the cervix uteri: a potential aid in the diagnosis of malignancy, J. Clin. Pathol. 1982:345-49.
Mikel, A Comparative Study of Quantitative Stains for DNA in Image Cytometry, Analytical and Quantitative Cytology and Histology vol. 13., No. 4 (Aug. 1991).
Leif, Centrifugal Cytology of Nipple Aspirate Cells, Acta Cytological Journal Vo. 24, No. 3 (May-Jun. 1980).
Klawe, Malignancy Associated Changes (MAC) in Cells of Buccal Smears Detected by Means of Objective Image Analysis, Acta Cytologica vol. 18, pp. 30-33 (1971).
Decosse, Feulgen Hydrolysis: Effect of Acid and Temperature, The Journal of Histography and Cytochemistry (1986).
Fukuda, Cytophotometry and Biological Application, Ch. 4: Biological Application of Absorbance Cytophotometry.
Fukuda, Cytophotometry and Biological Application, Ch. 3: Errors in Absorbance Cytophotometry.
Frenster, Physiology in Medicine: Gene De-Repression, New England Journal of Medicine Jun. 7, 1973.
Frenster, Repressed and Active Chromatin Isolated from Interphase Lymphocytes, Proc. N.A.S. pp. 1026-1032.
Frenster, Ultrastructural Continuity between Active and Repressed Chromatin, Nature Mar. 27, 1965.
Finch, Malignancy Associated Changes in Buccal Smears, Acta Cytologica, vol. 15, No. 1 (Jan.-Feb. 1971).
Kiellstrand, Temperature and Acid Concenctration in the Search for Optimum Feulgen Hydrolysis Conditions, The Journal of Histochemistry and Cytochemistry, vol. 25, No. 2, pp. 129-134 (1977).
Zelenin, Peculiarities of Cytochemical Properties of Cancer Cells as Revealed by Study of Deozyribonucleop(rotein Susceptibility to Feulgen Hydrolysis, The Journal of Histology and Cytochemistry, vol. 25, No. 7, pp. 580-584 (1977).
International Search Report dated Mar. 12, 2004 which issued in connection with corresponding PCT application No. PCT/CA03/01710.
PCT Written Opinion dated Aug. 12, 2004 which issued in connection with corresponding PCT application No. PCT/CA03/01710.
PCT International Preliminary Examination Report dated Mar. 4, 2005 which issued in connection with corresponding PCT application No. PCT/CA03/01710.
G6 Science Corp.
Trexler, Bushnell, Giangiorgi & Blackstone & Marr, Ltd
Wallenhorst Maureen M.
LandOfFree
Method of identifying and assessing DNA euchromatin in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of identifying and assessing DNA euchromatin in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of identifying and assessing DNA euchromatin in... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3704905